ScreenerHero

ANEBAnebulo Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · anebulo.com
0.3500USD-12.06%Mkt Cap: 14.27M $P/E: —

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the U…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap14.27M $
Enterprise Value5.23M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.48M $
Revenue/Share—
Last Price0.3500 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.54
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.81
EPS (TTM)-0.18
EPS (Forward)-0.65
52W Range
0.001012% of range2.900
52W High2.900 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.78%
ROA-69.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.35M $
CapEx (TTM)—
FCF Margin—
FCF Yield-26.44%
Net Debt-9.04M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio6.24
Quick Ratio6.12
Book Value/Sh0.1930 USD
Cash/Share0.2220 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.78M
Float24.13M
Insiders40.84%
Institutions0.00%
Short Interest
Short Ratio1.5d
Short % Float2.20%
Short % Out.0.36%
Shares Short146.37K
Short (prev mo.)58.05K
Technical
SMA 500.3481 (+0.5%)
SMA 2000.8835 (-60.4%)
Beta-1.82
S&P 52W Chg18.16%
Avg Vol (30d)290
Avg Vol (10d)260
Technical Indicators
RSI (14)52.6
MACD-0.0026
MACD Signal-0.0115
MACD Hist.+0.0089
BB Upper0.3686 USD
BB Middle0.3211 USD
BB Lower0.2736 USD
BB Width29.58%
ATR (14)0.0643 USD
Vol Ratio (20d)0.00x